Attention deficit hyperactivity disorder,autism,disruptive behaviour disorders such as oppositional defiant disorders and conduct disorders ,specific learning disorders
Conditions
Interventions
Omega-3 & omega-6 in the form of 280 mg of EPA and 100 mg of EPO in one capsule will be given twice a day. Any other medication the child is already taking will be continued as well as any non-pharmac
Sponsors
Habib Jaleel
Eligibility
Inclusion criteria
Inclusion criteria: The sample will be selected from among children aged 6-12 years, diagnosed with ADHD. Children already on medication and those without medication will be included. Also, children with ADHD and other comorbid disorders (oppositional disorders, learning disability, tic disorder and autism) will be included
Exclusion criteria
Exclusion criteria: Children with mental retardation as a primary diagnosis or as an associated condition will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcome will be measured at one month, three months and six months after the onset of treatment. Tools of assessment: 1.Diagnosis of behaviour disorder will be made using DSM IV TR criteria. Comorbid disorders will be similarly diagnosed. 2. SNAP IV completed by parent and teacher will be used to further validate the diagnosis and assess the severity of the symptoms. SDQ will be used to assess the specific symptoms of ADHD and its impact. 3. SNAP IV and SDQ will be used to objectively assess the outcome in 1 month, 3 months and 6 months in addition to the clinical assessment. 4. Structured psychometric assessments will be used to evaluate any learning difficulties in the child. 5. A clinical assessment will be made to gather information from parents regarding their perception of child’s behaviour and level of satisfaction with treatment. 6. A semi-structured questionnaire will be used to record bio-data and other patient and family related information [At 1 month, 3 months and 6 month after commencement of treatment ] | — |
Secondary
| Measure | Time frame |
|---|---|
| Asses for side effects such as tolerance [At 1 month, 3 months and 6 month after commencement of treatment] | — |
Countries
Sri Lanka
Contacts
Public ContactHemamali Perera
Professor in Psychological Medicine
Outcome results
None listed